CHAMP: Study of NVK-002 in Children With Myopia

NCT03350620 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

670

Enrollment

INDUSTRY

Sponsor class

Conditions

Myopia

Interventions

DRUG: NVK-002 Concentration 1
DRUG: NVK-002 Concentration 2
DRUG: Placebo

Sponsor

Vyluma, Inc.

Collaborators

[object Object]